(Q40122301)

17 September 2017

title

Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo (English)

1 reference

17 September 2017

1 reference

1 reference

1 reference

M M Alonso

1

1 reference

17 September 2017

C Gomez-Manzano

2

1 reference

17 September 2017

H Jiang

3

1 reference

17 September 2017

N B Bekele

4

1 reference

17 September 2017

Y Piao

5

1 reference

17 September 2017

W K A Yung

6

1 reference

17 September 2017

R Alemany

7

1 reference

17 September 2017

J Fueyo

8

1 reference

17 September 2017

publication date

8 June 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

14

1 reference

17 September 2017

issue

8

1 reference

17 September 2017

page(s)

756-761

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701067

17 September 2017

exact match

0 references

cites work

Malignant glioma: genetics and biology of a grave matter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Optimal role of temozolomide in the treatment of malignant gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Generalized Equations for the Analysis of Inhibitions of Michaelis-Menten and Higher-Order Kinetic Systems with Two or More Mutually Exclusive and Nonexclusive Inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Use of replicating oncolytic adenoviruses in combination therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701067

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701067

1 reference

Dimensions Publication ID

17 September 2017

1026659194

0 references

1 reference